An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC) Intervention: Drug: Maralixibat Sponsor: Mirum Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials